The estimated Net Worth of Jennifer B. Damico is at least $1.68 Milión dollars as of 13 August 2024. Jennifer Damico owns over 5,154 units of Pfizer stock worth over $254,542 and over the last 5 years he sold PFE stock worth over $1,425,862. In addition, he makes $0 as Senior Vice President, Principal Accounting Officer a Controller at Pfizer.
Jennifer has made over 16 trades of the Pfizer stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 5,154 units of PFE stock worth $147,714 on 13 August 2024.
The largest trade he's ever made was exercising 12,477 units of Pfizer stock on 25 February 2021 worth over $285,599. On average, Jennifer trades about 876 units every 13 days since 2020. As of 13 August 2024 he still owns at least 8,582 units of Pfizer stock.
You can see the complete history of Jennifer Damico stock trades at the bottom of the page.
Jennifer Damico is the Senior Vice President, Principal Accounting Officer, Controller at Pfizer.
Jennifer Damico is 52, he's been the Senior Vice President, Principal Accounting Officer a Controller of Pfizer since 2020. There are 27 older and 2 younger executives at Pfizer. The oldest executive at Pfizer Inc. is Wyllie Don Cornwell, 72, who is the Independent Director.
Jennifer's mailing address filed with the SEC is 66 HUDSON BOULEVARD EAST, ATTN: CORPORATE SECRETARY, NEW YORK, NY, 10001-2192.
Over the last 12 years, insiders at Pfizer have traded over $216,003,942 worth of Pfizer stock and bought 24,324 units worth $872,198 . The most active insiders traders include Shantanu Narayen, Ian C Read a James M Kilts. On average, Pfizer executives and independent directors trade stock every 12 days with the average trade being worth of $2,169,896. The most recent stock trade was executed by Jennifer B. Damico on 13 August 2024, trading 5,154 units of PFE stock currently worth $147,714.
Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered at The Spiral in Manhattan, New York City. The company was established in 1849 in New York by two German entrepreneurs, Charles Pfizer and his cousin Charles F. Erhart.
Pfizer executives and other stock owners filed with the SEC include: